AIDS News and Research

RSS

AIDS 2010 opens: Leaders weigh in on global HIV/AIDS funding; Clinton, Gates on efficiency

The six-day International AIDS Conference-AIDS 2010 kicked off Sunday in Vienna, Austria "amid resurgent fears that advances in the 29-year war against the disease were threatened by a slump in funding," Agence France-Presse reports.

20 Jul 2010

PSI showcases evidence-based HIV prevention methods at International AIDS Conference

Technical staff from PSI, a leading global health organization operating in more than 60 countries around the world, are currently attending the 18th International AIDS Conference in Vienna to showcase PSI's innovative, evidence-based HIV prevention methods, which have helped to successfully avert more than one billion cases of HIV infection over the past 40 years.

20 Jul 2010

A look into HIV related issues

According to a report from US health officials, the poorer neighborhoods of America's cities harbour at least 1 in 50 heterosexual adults infected with HIV. These figures are more than elsewhere in the country. According to the research team from the U.S. Centers for Disease Control and Prevention (CDC), being poor and getting HIV are linked and this was regardless of race or ethnicity.

19 Jul 2010

Today's OpEds: Public opinion and health reform; Hospitals and cost cuts; Medicare fraud 'gusher'

Less than four months after Congress approved historic health care reform legislation, the Obama administration has been making good progress in bringing some early benefits to fruition and issuing rules to guide the reform process. Despite all of the critics' hype and scare tactics, some polls suggest that the public perception of reform is slowly improving (7/18).

19 Jul 2010

First Edition: July 19, 2010

Today's headlines include the latest news regarding the politics of implementing health reform as well as developments from the international AIDS conference now underway in Vienna.

19 Jul 2010

Phase II data on Genetic Immunity's DermaVir vaccine to be presented at XVIII International AIDS Conference

Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine-based immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data on the Company's novel DermaVir therapeutic vaccine for HIV/AIDS during the XVIII International AIDS Conference this week in Vienna, Austria. DermaVir, the first dendritic cell-targeting topical HIV vaccine candidate, employs nanotechnology to induce multi-faceted and long-lived immune responses capable of eliminating HIV infected cells.

19 Jul 2010

ViroStatics to present VS411 Phase II dose-ranging trial data at International AIDS Conference in Vienna

ViroStatics, a US/Italian biopharmaceutical company developing innovative immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data from a randomized, dose-ranging trial of VS411, the Company's novel combination product for treating HIV/AIDS, during the XVII International AIDS Conference this week in Vienna, Austria.

19 Jul 2010

FIT Biotech to present results of FIT-06 Phase II clinical trial at XVIII International AIDS 2010 Conference

FIT Biotech, a privately held biotechnology company developing novel, proprietary immunotherapies for HIV/AIDS and other viral diseases, announced results today from a Phase II clinical trial. The company's immunomodulator FIT-06 showed unprecedented long-term reductions in viral load (approximately 0.5 log) and statistically significant CD4 cell count increases in HIV-infected, previously untreated patients. The effect lasted longer than two years in the absence of any anti-retroviral therapy.

19 Jul 2010

Effective AIDS treatment but poor accessibility: Report from International AIDS conference 2010

At the 18th AIDS conference 2010 in Vienna, Julio Montaner — the President of the International AIDS Society and Chairman of the AIDS 2010 conference said this Sunday that the G-8 countries were not doing enough to ensure treatment of all people infected with HIV and AIDS. He said, “This is a very serious deficit… Let's rejoice in the fact that today we have treatments that work ... what we need is the political will to go the extra mile to deliver universal access.”

18 Jul 2010

Cash incentives cut down HIV transmission: World Bank Studies

A cash incentive has been found to lower the rates of HIV and sexually transmitted disease transmission among Malawian and Tanzanian youths revealed the World Bank, this Sunday. There were two studies undertaken to make this connection.

18 Jul 2010

New microfluidic device for effective HIV diagnosis

UC Davis biomedical engineer Prof. Alexander Revzin has developed a "lab on a chip" device for HIV testing. Revzin's microfluidic device uses antibodies to "capture" white blood cells called T cells that are affected by HIV. In addition to physically binding these cells the test detects the types and levels of inflammatory proteins (cytokines) released by the cells.

17 Jul 2010

IAS announces winners of four scientific awards to be presented at AIDS 2010

The International AIDS Society (IAS) announced today the ten winners of four prestigious scientific awards, to be presented at plenary sessions during the XVIII International AIDS Conference (AIDS 2010). Presented by the IAS and partners, these awards recognize scientists involved in innovative HIV and AIDS research throughout the world. "The quality of work represented by the 2010 awardees is remarkable," said IAS President Julio Montaner. "The IAS hopes to draw the world's attention to these individuals and to their significant scientific accomplishments, as well as to the continued need for innovation in all of the major areas of HIV and AIDS research, represented by the six conference programme tracks."

17 Jul 2010

Study examines HIV-positive patients' death risk at CD4 counts above 350

"Having HIV appears to be associated with a greater risk of death, even when the immune system is relatively robust and patients have not started treatment," according to a study published Friday in the Lancet, MedPage Today reports (Smith, 7/15).

17 Jul 2010

CDC director gives health system failing grade on prevention

Memphis Commercial Appeal: "The American health care system gets an 'F' when it comes to acting on a handful of prevention methods that have the potential to save the most lives. That failing grade came from Dr. Thomas Frieden, director of the Centers for Disease Control and Prevention, in a Wednesday speech to members of the National Association of County and City Health Officials gathered here for their annual conference at Cook Convention Center."

17 Jul 2010

Recent releases in Global Health

As part of a series in advance of AIDS 2010, the "Science Speaks" blog features an interview with U.S. Global AIDS Coordinator Eric Goosby "about his expectations for the conference, what was behind the Uganda problem with shortages of AIDS medicine, and whether The New York Times was right when it reported in May that the Ugandan drug shortfall was 'the first example … of how the war on AIDS is falling apart.'"

16 Jul 2010

AU summit meetings to focus on maternal, child health

African Union (AU) summit delegates have started arriving in Uganda for a series of meetings ahead of the 15th AU Summit, which takes place July 19-27 in the capital of Kampala, the New Vision reports (Musoke, 7/14).

16 Jul 2010

Bill Gates emphasizes need for increased efficiency in HIV prevention, treatment programs

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, "urged governments and health advocates Tuesday to 'get more out of every dollar' in the fight against AIDS, saying the global economic downturn has hit funding for the disease," Agence France-Presse reports.

16 Jul 2010

Early HIV treatment reduces death, likelihood of TB, study finds

"Early treatment for HIV cuts patients' risk of death by about 75 percent," according to a study conducted in Haiti and published Thursday in the New England Journal of Medicine, Bloomberg Businessweek reports. The study also demonstrated that "early antiretroviral treatment reduces the likelihood of tuberculosis, a leading cause of death among HIV patients, by 50 percent," the news service writes (Aquino, 7/14).

16 Jul 2010

New findings on macrophage activation can facilitate development of early diagnosis tools

Immune system cells called macrophages spring into action to surround and destroy threats such as viruses or cancer cells. But sometimes the would-be protective response leads to persistent inflammation, which, in turn, can cause disease.Scientists don't know exactly how macrophages cross the line from being good cops to bad cops, but researchers at the University of Florida recently unearthed several clues about the mechanisms involved. Through the lens of two inflammation-related diseases, HIV and rheumatoid arthritis, they identified changes in specific proteins linked to the action of macrophages, white blood cells that are key to the body's natural defenses.

16 Jul 2010

Shrink Nanotechnologies files patent applications for CellAlign advanced tissue engineering technology

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that certain patent applications related to its advanced tissue engineering technology platform, CellAlign™, have been filed.

15 Jul 2010

AIDS News and Research

AIDS 2010 opens: Leaders weigh in on global HIV/AIDS funding; Clinton, Gates on efficiency

PSI showcases evidence-based HIV prevention methods at International AIDS Conference

A look into HIV related issues

Today's OpEds: Public opinion and health reform; Hospitals and cost cuts; Medicare fraud 'gusher'

First Edition: July 19, 2010

Phase II data on Genetic Immunity's DermaVir vaccine to be presented at XVIII International AIDS Conference

ViroStatics to present VS411 Phase II dose-ranging trial data at International AIDS Conference in Vienna

FIT Biotech to present results of FIT-06 Phase II clinical trial at XVIII International AIDS 2010 Conference

Effective AIDS treatment but poor accessibility: Report from International AIDS conference 2010

Cash incentives cut down HIV transmission: World Bank Studies

New microfluidic device for effective HIV diagnosis

IAS announces winners of four scientific awards to be presented at AIDS 2010

Study examines HIV-positive patients' death risk at CD4 counts above 350

CDC director gives health system failing grade on prevention

Recent releases in Global Health

AU summit meetings to focus on maternal, child health

Bill Gates emphasizes need for increased efficiency in HIV prevention, treatment programs

Early HIV treatment reduces death, likelihood of TB, study finds

New findings on macrophage activation can facilitate development of early diagnosis tools

Shrink Nanotechnologies files patent applications for CellAlign advanced tissue engineering technology

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News